The Library of Congress >  Researchers >  Search Finding Aids  >  Frances Oldham Kelsey papers, 1890-2016

Frances Oldham Kelsey papers, 1890-2016

Contact UsHelpSearch All Finding Aids
Access restrictions apply.Some or all content stored offsite.
Part I: Research File, 1917-1998 (continued)
BOX I:16 DES (Drug)
BOX I:16 Correspondence, 1950-1978
BOX I:16 Memoranda, 1970-1978
BOX I:16 Miscellany, 1950-1978, undated
BOX I:16 Press releases, 1972
BOX I:16 Printed matter, 1948-1985, undated
(2 folders)
BOX I:16 Reports and statements, 1972-1979, undated
BOX I:16 Task force, 1978
BOX I:16 Diapulse device, 1967, 1995
BOX I:16 Dihydrostreptomycin (DHSM), 1953, 1962, undated
BOX I:16 Division of Biologics Standards, U.S. Food and Drug Administration, 1972-1976
BOX I:16 Division of Scientific Investigations, U.S. Food and Drug Administration, 1964, 1985-1987, undated
BOX I:16 DMSO (Drug)
BOX I:16 Bibliography, 1964
BOX I:16 Correspondence, 1965-1967, 1980-1981
(2 folders)
BOX I:17 Leake, Chauncey Depew, consulting editor, Biological Actions of Dimethyl Sulfoxide, 1967
BOX I:17 McGrady, Pat, The Persecuted Drug: The Story of DMSO, 1980
BOX I:17 Memoranda
BOX I:17 Conferences, 1965, 1980-1981
BOX I:17 Miscellaneous, 1965-1966, 1980-1981
BOX I:17 Office, 1964-1988
(2 folders)
BOX I:17 Telephone conversations, 1965-1980
BOX I:17 Miscellany, 1965, undated
BOX I:17 Press releases, 1964-1981
BOX I:18 Printed matter, 1965-1982, undated
(2 folders)
BOX I:18 Reports and statements, 1965-1966, undated
BOX I:18 Subcommittee on Health and Scientific Research, Senate Committee on Labor and Human Resources, hearing and exhibits, 1980, undated
BOX I:18 Dornwal, 1961-1964, undated
BOX I:18 Drug efficacy study, National Academy of Sciences-National Research Council, 1969, undated
BOX I:18 Drug Research Board, National Academy of Sciences-National Research Council, 1965
BOX I:18 Dyes, 1936, 1960-1989, undated
BOX I:18 Elavil, 1961-1963, undated
BOX I:18 Equal rights for women in the federal government, 1962-1972
BOX I:18 Estrogenic substances in plants, 1959, undated
BOX I:19 Fluoridation, 1960-1979, 1990, undated
(4 folders)
BOX I:19 Fluorouracil, 1961-1962, undated
BOX I:19 Furaltadone (Altafur), 1961
BOX I:19 Galega, 1965-1967
BOX I:19 Gestest, 1961, undated
BOX I:19 Hi and Dry (cream deodorant), 1961, undated
BOX I:19 Hypertension, 1961-1962, undated
BOX I:19 International Clearinghouse for Birth Defects Monitoring Systems, 1972-1978, undated
BOX I:19 Investigational Drug Branch, U.S. Food and Drug Administration, 1966
BOX I:19 Investigational new drugs (INDs)
BOX I:19 Adverse comments, Division of Toxicological Evaluation, 1966
BOX I:19 Comments on regulatory procedures, 1961-1975, undated
(2 folders)
BOX I:20 Division of Oncology and Radiopharmaceutical Drug Products, U.S. Food and Drug Administration, 1966-1967
BOX I:20 Inventory of early INDs, 1963
BOX I:20 Proposed regulations and revisions, 1938, 1962-1975, undated
BOX I:20 Regulatory language, series form paragraphs, undated
BOX I:20 Treatment, 1981-1990
(2 folders)
BOX I:20 Kevadon See Container I:33 , Kevadon literature
BOX I:20 Krebiozen, 1959-1982, undated
BOX I:20 Lactostat and climacterin, 1961-1962, undated
BOX I:21 Laetrile, 1967-1983, undated
(5 folders)
BOX I:21 Lavema, 1961, undated
BOX I:21 Leake, Chauncey Depew
BOX I:21 Obituary, 1978
BOX I:21 "Preserving Our Science Archives," Science, 1960
BOX I:21 Lentran, 1961-1962, undated
BOX I:21 Ley, Herbert L., testimony regarding drug testing problems and the role of the U.S. Food and Drug Administration, 1969
BOX I:21 Librium, 1961-1962, undated
BOX I:21 Lin, Chíao-chih, and other Chinese physicians on tour in the United States, 1945, 1972
BOX I:21 Listica, 1960-1962, undated
BOX I:21 Lithium, 1966
BOX I:21 LSD (Drug), 1994
BOX I:21 Medical Fluid 360, 1966
BOX I:21 Megazyme, 1962, undated
BOX I:22 Mental Health Law Project (phenothiazines in institutions), 1964-1974
BOX I:22 Meprobamate, 1958-1966
BOX I:22 Merital, 1986-1990
(2 folders)
BOX I:22 Methotrexate, 1961
BOX I:22 Miscellany, 1963-1996, undated
BOX I:22 MK 665 (Drug), 1966
BOX I:22 Monase, 1960-1963, undated
BOX I:22 Myosed, 1961-1962, undated
BOX I:22 National Center for Drugs and Biologics, U.S. Food and Drug Administration, 1972, 1983-1984
BOX I:22 National Library of Medicine, Bethesda, Md., computerization of scientific information, 1961-1964
BOX I:22 New drug applications (NDAs), U.S. Food and Drug Administration
BOX I:22 Logs, 1957-1961
(2 folders)
BOX I:23 Reviews, 1963
BOX I:23 New Drug Branch, U.S. Food and Drug Administration, 1960
BOX I:23 Nicotinamide adenine dinucleotide (NAD), 1966-1968, 1989
BOX I:23 Nitrogen mustards, undated
BOX I:23 Nobrium, 1956-1962, undated
BOX I:23 Norlutin, 1961, undated
BOX I:23 Ocular Drug Toxicities Symposium, Bethesda, Md., 1966-1971
BOX I:23 Orphan drugs, 1977-1992
BOX I:23 Parotin, 1963
BOX I:23 Patient package inserts, 1969-1990, undated
(2 folders)
BOX I:23 Potassium thiazide, 1964-1965, undated
BOX I:23 Practolol, 1980
BOX I:23 Preludin, 1957-1962, undated
BOX I:23 Prescribing authority for pharmacists, 1983
BOX I:23 Prescription drug labeling, 1969-1990, undated
BOX I:23 Procaine with polyvinylpyrrolidone (PVP)
BOX I:23 1964-1980
BOX I:24 1983-1986, undated
(2 folders)
BOX I:24 Prodilidine, 1961-1962, undated
BOX I:24 Progonasyl, 1971-1973
BOX I:24 Propoquin, 1962, undated
BOX I:24 Quackery
BOX I:24 1954-1988
(4 folders)
BOX I:25 1989-1992, undated
(2 folders)
BOX I:25 Radiochromate injection, 1961, undated
BOX I:25 Radio-rose bengal, 1961-1962, undated
BOX I:25 Ramps (Campanula rapunculus), 1969-1977
BOX I:25 Rand cancer vaccine, 1966-1967
BOX I:25 Rectalad, undated
BOX I:25 Reports
BOX I:25 Annual reports, Center for the Study of Drug Development, 1985-1987
Next Page »

Contents List